The Relationship between Serum Vitamin D Levels, C-Reactive Protein, and Anxiety Symptoms
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: The aim of study is to investigate the relationship between serum vitamin D, c-reactive protein (CRP) levels, and anxiety symptoms. Methods: Serum vitamin D and CRP levels of 51,003 Korean adult participants were collected retrospectively. Anxiety symptoms were assessed using the Korean version of Beck Anxiety Inventory. Logistic regression was used to estimate the odds ratio (ORs) of anxiety symptoms by serum vitamin D and CRP levels. The regression was adjusted for covariates, and each model was adjusted mutually for vitamin D and CRP levels. Results: Compared with sufficient vitamin D levels (≥20 ng/mL), insufficient (10–19.99 ng/mL) and deficient (<10 ng/mL) vitamin D levels were significantly associated with risk of anxiety symptoms. Also, continuous vitamin D levels were negatively associated with the risk of anxiety symptoms. CRP levels did not affect the relationship between vitamin D levels and risk of anxiety symptoms. Conclusion: Insufficient (10–19.99 ng/mL) and deficient (<10 ng/mL) vitamin D levels were significantly associated with risk of anxiety symptoms. After adjusting for CRP levels, the results were not changed, and no evidence of interaction between vitamin D and CRP levels was found. CRP levels did not account for the association between vitamin D levels and risk of anxiety symptoms.
Abstract
Objective: The aim of study is to investigate the relationship between serum vitamin D, c-reactive protein (CRP) levels, and anxiety symptoms. Methods: Serum vitamin D and CRP levels of 51,003 Korean adult participants were collected retrospectively. Anxiety symptoms were assessed using the Korean version of Beck Anxiety Inventory. Logistic regression was used to estimate the odds ratio (ORs) of anxiety symptoms by serum vitamin D and CRP levels. The regression was adjusted for covariates, and each model was adjusted mutually for vitamin D and CRP levels. Results: Compared with sufficient vitamin D levels (≥20 ng/mL), insufficient (10–19.99 ng/mL) and deficient (<10 ng/mL) vitamin D levels were significantly associated with risk of anxiety symptoms. Also, continuous vitamin D levels were negatively associated with the risk of anxiety symptoms. CRP levels did not affect the relationship between vitamin D levels and risk of anxiety symptoms. Conclusion: Insufficient (10–19.99 ng/mL) and deficient (<10 ng/mL) vitamin D levels were significantly associated with risk of anxiety symptoms. After adjusting for CRP levels, the results were not changed, and no evidence of interaction between vitamin D and CRP levels was found. CRP levels did not account for the association between vitamin D levels and risk of anxiety symptoms.
참고문헌 (31)
- Baxter AJ, "Global prevalence of anxiety disorders : a systematic review and meta-regression", Psychol Med, 43, pp.897~910 (2013)
- Roy-Byrne P, "Treatment-refractory anxiety; definition, risk factors, and treatment challenges", Dialogues Clin Neurosci, 17, pp.191~206 (2015)
- Parker GB, "Vitamin D and depression", J Affect Disord, 208, pp.56~61 (2017)
- Wood JM, "Vitamin D and neurocognitive disorder due to Alzheimer’s disease : A review of the literature", Ann Clin Psychiatry, 27, pp.e1~e7 (2015)
- Belvederi Murri M, "Vitamin D and psychosis : mini meta-analysis", Schizophr Res, 150, pp.235~239 (2013)
- Jia F, "Bench to bedside review : possible role of vitamin D in autism spectrum disorder", Psychiatry Res, 260, pp.360~365 (2018)
- Neighbors CLP, "Vitamin D and obstructive sleep apnea : a systematic review and meta-analysis", Sleep Med, 43, pp.100~108 (2018)
- Armstrong DJ, "Vitamin D deficiency is associated with anxiety and depression in fibromyalgia", Clin Rheumatol, 26, pp.551~554 (2007)
- de Koning EJ, "The relationship between serum 25(OH)D levels and anxiety symptoms in older persons : results from the Longitudinal Aging Study Amsterdam", J Psychosom Res, 97, pp.90~95 (2017)
- Wu C, "Association between serum levels of vitamin D and the risk of post-stroke anxiety", Medicine (Baltimore), 95, pp.e3566~ (2016)
- Colotta F, "Modulation of inflammatory and immune responses by vitamin D", J Autoimmun, 85, pp.78~97 (2017)
- Glaus J, "The bidirectional relationship between anxiety disorders and circulating levels of inflammatory markers : Results from a large longitudinal population-based study", Depress Anxiety, 35, pp.360~371 (2018)
- Naude PJW, "Anxiety disorders and CRP in a population cohort study with 54, 326 participants : the LifeLines study", World J Biol Psychiatry, 19, pp.461~470 (2018)
- Vogelzangs N, "Anxiety disorders and inflammation in a large adult cohort", Transl Psychiatry, 3, pp.e249~ (2013)
- Gabay C, "Acute-phase proteins and other systemic responses to inflammation", N Engl J Med, 340, pp.448~454 (1999)
- Herrick KA, "Vitamin D status in the United States, 2011-2014", Am J Clin Nutr, 110, pp.150~157 (2019)
- 정인경, "한국인의 비타민 D 부족 유병률에 관한 연구:국민건강영양조사 2010~2011 분석결과", Journal of Nutrition and Health, 46(6), pp.540~551 (2013), 한국영양학회[DOI]
- Thacher TD, "Vitamin D insufficiency", Mayo Clinic Proc, 86, pp.50~60 (2011)
- Kwon SM, "Differential causal roles of dysfunctional attitudes and automatic thoughts in depression", Cogn Ther Res, 16, pp.309~328 (1992)
- 이한경, "Psychometric Properties of the Beck Anxiety Inventory in the Community-dwelling Sample of Korean Adults", Korean Journal of Clinical Psychology, 35(4), pp.822~830 (2016), 한국임상심리학회[DOI]
- Yook S, "A clinical study on the Korean version of Beck Anxiety Inventory : comparative study of patient and non-patient", Korean J Clin Psychol, 16, pp.185~197 (1997)
- Beck AT, "An inventory for measuring clinical anxiety : psychometric properties", J Consult Clin Psychol, 56, pp.893~ (1988)
- Lee B, "Development of Korean version of alcohol use disorders identification test(AUDIT-K) : Its reliability and validity", J Korean Acad Addict Psychiatry, 4, pp.83~92 (2000)
- Wortsman J, "Decreased bioavailability of vitamin D in obesity", Am J Clin Nutr, 72, pp.690~693 (2000)
- Eyles DW, "Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain", J Chem Neuroanat, 29, pp.21~30 (2005)
- Kalueff AV, "Increased anxiety in mice lacking vitamin D receptor gene", Neuroreport, 15, pp.1271~1274 (2004)
- Patrick RP, "Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism", Faseb J, 28, pp.2398~2413 (2014)
- Griffin MD, "Vitamin D and its analogs as regulators of immune activation and antigen presentation", Ann Rev Nutr, 23, pp.117~145 (2003)
- Felger JC, "Imaging the role of inflammation in mood and anxiety-related disorders", Curr Neuropharmacol, 16, pp.533~558 (2018)
- Michopoulos V, "Inflammation in fear-and anxiety-based disorders : PTSD, GAD, and beyond", Neuropsychopharmacology, 42, pp.254~270 (2017)
- Park JH, "Vitamin D status in South Korean population: Seven-year trend from the KNHANES", Medicine(Baltimore), 97, pp.e11032~ (2018)